Skip to the reading

Minnesota · Care fieldnotes

What a “research only” label leaves out

You may see “research use only” beside a product that also talks about health or healing. That mismatch is a reason to stop and ask what is actually being offered.

Source check: September 26, 2026.

The label does not decide the law

Letters from the federal drug agency, the FDA, say a research label does not shield products marketed for people from drug law, as checked September 26, 2026.

The letters alleged unlawful sales of unapproved drugs. An unapproved drug is one without FDA approval.

Those letters concern particular sellers. They state what the FDA accused the sellers of doing; they are not court decisions.

“Research” on a sales page is not the same as taking part in a medical study. Ask what evidence supports the proposed care, not what the package calls itself.

Names that need an approval check

BPC-157 and ipamorelin are names of peptide ingredients sold online. A check of FDA records on September 26, 2026, found no approved United States medicine containing either one.

Retatrutide is an ingredient in products offered for weight loss. The same record check found no approved United States medicine containing it.

Cagrilintide is another ingredient named in the FDA’s warnings about unapproved weight medicines.

For BPC-157 and ipamorelin, the records checked here do not identify an approved health problem to treat. If either is offered to you, ask what it is supposed to help and what evidence supports that claim.

A medicine’s lack of FDA approval alone cannot settle whether a pharmacy is legally allowed to prepare it. Compounding, or mixing a medicine for a patient, has separate ingredient rules. A prescription does not remove those rules.

When a pharmacy prepares medicine for one patient, the ingredient has to meet any existing official standard for drug quality. Without that standard, it must be in an approved drug. When neither condition is met, the ingredient has to appear on the FDA’s list of allowed ingredients.

As of September 26, 2026, the FDA says retatrutide and cagrilintide cannot legally be used in compounded medicines. A pharmacy cannot make either one for you under those rules.

Bring the claim back to a care question

Ask the person treating you: “What is the exact medicine? Is it approved, and can it legally be supplied to me? What other options could help my concern?” A product page cannot answer those questions for your own health.

Keep the source in reach

Before you move on

A research label is a label, not an approval or a care plan. Keep the product’s exact name and ask about its status.

Look at other claims that need a check